immunotherapychemotherapieshormonal therapiesimmunotherapy-basedSipuleucel-Tprostate cancermCRPCUS Food and Drug AdministrationProvenge
…y “cold” tumor. Sipuleucel-T (Provenge), an autologous cellular immunotherapy, induces an immune response targeted against prostatic acid pho…